Investing.com – Cogent Biosciences (NASDAQ: ) Q4 reports missing analyst estimates. The income is at the same level as the predicted figure. According to information released on Monday Cogent Biosciences (EPS) earnings per share was $-0.630 on revenue of The post Cogent Biosciences Misses Analyst Estimates in Q4 Earnings Report, Healthcare Sector Earnings Comparison appeared first on News Directory 3.
technology today: 2024-05-02 15:45:00
May 2, 2024
No Comments